Literature DB >> 7355944

Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy.

C Levy, P Robel, J P Gautray, J De Brux, U Verma, B Descomps, E E Baulieu.   

Abstract

Estradiol and progesterone receptor sites (empty or filled with endogenous hormone)have been measured in the cytoplasm and nuclei of human endometrium. Receptor changes have been observed throughout the normal menstrual cycle. During the preovulatory phase the cytoplasmic estradiol receptor sites do not change while the nuclear receptor sites more than double. Cytoplasmic estradiol receptor sites decrease very early in the secretory phase, whereas the decrease in nuclear sites occurs later. Cytoplasmic progesterone receptor sites more than double during the preovulatory phase and show a large decrease immediately after ovulation, when the concentration of nuclear receptor is at its highest. Thus the total cellular concentrations of both estradiol and progesterone receptors are lowest in the late secretory phase. It was found that they are positively correlated with the concentration of plasma estradiol only during the proliferative phase. The concentration of cytoplasmic progesterone receptor is negatively correlated with 17 beta-hydroxysteroid oxidoreductase activity during the secretory phase. In anovulatory cycles the concentrations of estradiol and progesterone receptors are high, similar to those of the late proliferative phase. "luteal insufficiency" is characterized by a very low concentration of estradiol receptor. Early pregnancy endometrium (8 to 10 weeks' gestation) is characterized by a large concentration of progesterone receptor, exceeding those of any period of the menstrual cycle.

Entities:  

Keywords:  Anovulation; Biology; Clinical Research; Endocrine System; Endometrium; Estradiol; Estrogens; Genitalia; Genitalia, Female; Hormone Receptors; Hormones; Membrane Proteins; Menstrual Cycle; Menstruation; Menstruation Disorders; Ovarian Effects; Ovary; Physiology; Pregnancy; Pregnancy, First Trimester; Progestational Hormones; Progesterone; Reproduction; Research Methodology; Urogenital System; Uterus

Mesh:

Substances:

Year:  1980        PMID: 7355944     DOI: 10.1016/0002-9378(80)91018-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  Expression of estradiol and progesterone receptors by histologically normal endometria of women with postmenopausal bleeding.

Authors:  G I Gorodeski; C M Bahary
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

Review 2.  Contragestion by antiprogestin RU 486: a review.

Authors:  E E Baulieu; A Ulmann; D Philibert
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

Review 3.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

4.  Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.

Authors:  Peng Wang; Neeraja Dharmaraj; Melissa J Brayman; Daniel D Carson
Journal:  Mol Endocrinol       Date:  2010-05-19

5.  Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria.

Authors:  H Pickartz; R Beckmann; B Fleige; W Düe; J Gerdes; H Stein
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Distribution of total progesterone receptor levels in various segments and tissues of the normal human uterus: the effect of short-term estrogen administration.

Authors:  I G Gorodeski; C M Bahary; B Lunenfeld; R Beery; A Geier
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

7.  [Physiology of the menstrual cycle].

Authors:  W Braendle
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

8.  Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast.

Authors:  K S McCarty; J S Silva; E B Cox; G S Leight; S A Wells; K S McCarty
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

Review 9.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

10.  Immunohistochemical study of distribution of estrogen receptors in corpus and cervix uteri.

Authors:  A Scharl; M Vierbuchen; J Graupner; R Fischer; A Bolte
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.